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Introduction
Cryopyrin-associated periodic syndromes (CAPS) are a
spectrum of autoinflammatory disesase with spontaneous
activation of the NLRP3 inflammasome, leading to hyper-
secretion of IL-1b. To date, more than 90 mutations have
been described in NLRP3,primarily in exon 3, leading to
the autoinflammatory symptoms observed in CAPS.
Here, we describe a family with autosomal dominantly
inherited, unilateral sensorineural hearing loss, found to
have a novel mutation in exon 7 of NLRP3.
Objective
To evaluate the clinical and genetic features of a
2-generation pedigree with unilateral sensorineural hearing
loss.
Methods
Patient data, including audiologic studies, and detailed
family history was obtained. DNA was isolated using saliva
samples from all family members and Sanger sequencing
of all 9 exons of NLRP3 was performed.
Results
The proband was first identified during an evaluation
for recurrent fevers and aphthous stomatitis, occurring
2-3 times per month, beginning at 4 months of age,
without infectious etiology. Episodes were not associated
with cold exposures or rash. Physical exam was notable
for an otherwise well appearing child, without evidence
for inflammation or autoantibodies. At the age of 5, he
was noted to have unilateral sensorineural hearing loss
in the range of 4000-8000 Hz, similar to his father. Two
younger siblings were noted to have similar symptoms,
with similar age of onset, including unilateral hearing
loss. Between flares, ESR and high sensitivity CRP were
normal in all three children suggesting an absence of
chronic inflammation. We identified a novel variant in
NLRP3 exon 7: c.2753 G>A, R918Q in all 4 affected
members of this 5-person pedigree. Modeling of the
mutation localizes the substituted amino acid residue to
the inner surface of the LRR domain and suggests an
alteration in charge distribution predicted to affect inter
or intraprotein protein-protein interactions.
Conclusions
While bilateral sensorineural hearing loss has been
described in association with Muckle Wells Syndrome and
Neonatal onset multi-inflammatory disease (NOMID),
both on the CAPS spectrum, in this family, a novel
NLRP3 variant was associated with unilateral hearing loss
in the absence of serologic evidence for chronic inflamma-
tion. This is the first potentially disease associated variant
to be described in exon 7 of NLRP3.
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